secwatch.observer — SEC 8-K summary
======================================

Issuer:     RECURSION PHARMACEUTICALS, INC. (RXRX)
CIK:        0001601830
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001601830-25-000008
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud

Recursion Pharmaceuticals releases updated investor presentation for JP Morgan Healthcare Conference
--------------------------------------------------------------------------------

- Investor presentation dated January 13, 2025 attached as Exhibit 99.1
- Presentation to be used at JP Morgan Healthcare Conference and in investor meetings
- CEO Christopher Gibson signed the 8-K filing on January 13, 2025
- Information furnished under Item 7.01 not deemed filed for SEC purposes

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601830/000160183025000008/0001601830-25-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601830/000160183025000008/rxrx-20250113.htm
  HTML page:      https://secwatch.observer/filing/0001601830-25-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer